Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
High Frequency of Nonclassical Steroid 21-Hydroxylase Deficiency
1986430 citationsPhyllis Speiser, Bo Dupont et al.Obstetrical & Gynecological Surveyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of A Kaštelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kaštelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kaštelan more than expected).
This network shows the impact of papers produced by A Kaštelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kaštelan. The network helps show where A Kaštelan may publish in the future.
Co-authorship network of co-authors of A Kaštelan
This figure shows the co-authorship network connecting the top 25 collaborators of A Kaštelan.
A scholar is included among the top collaborators of A Kaštelan based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Kaštelan. A Kaštelan is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Žunec, Renata, et al.. (2004). HLA-DQ2 HETERODIMER IN THE DIAGNOSIS OF CELIAC DISEASE. 14. 119–124.2 indexed citations
4.
Grubić, Zorana, et al.. (2001). [Variation in HLA-B27 gene subtypes and susceptibility of ankylosing spondylitis in the Croatian population].. PubMed. 48(1). 7–11.10 indexed citations
5.
Grubić, Zorana, et al.. (2000). Distribution of alleles at DQCAR microsatellite locus in the Croatian population.. PubMed. 41(3). 298–302.
6.
Grubić, Zorana, et al.. (1999). Comparison of serology and DNA methods for HLA-Cw typing in the Croatian population. Periodicum Biologorum. 101(1). 71–75.1 indexed citations
7.
Grubić, Zorana, et al.. (1998). Implication of molecular analysis of HLA-A*02 subtyping for unrelated bone-marrow donor selection.. PubMed. 22 Suppl 4. S27–30.2 indexed citations
Speiser, Phyllis, Bo Dupont, Pablo Rubinstein, et al.. (1986). High Frequency of Nonclassical Steroid 21-Hydroxylase Deficiency. Obstetrical & Gynecological Survey. 41(4). 244–245.430 indexed citations breakdown →
14.
Labar, Boris, et al.. (1984). [Transplantation of bone marrow in the treatment of severe aplastic anemia].. PubMed. 106(6). 219–23.1 indexed citations
15.
Dumić, M, et al.. (1983). [Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency - different HLA genotypes in 2 brothers].. PubMed. 105(4). 145–9.2 indexed citations
Kaštelan, A, et al.. (1976). The effect of thymectomy on the competitive potential of C57BL/6 bone marrow graft.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(4). 201–8.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.